Themis Medicare Limited Announces Key Management Change
Themis Medicare Limited has announced a key management change with the resignation of its Company Secretary and Compliance Officer. The pharmaceutical company informed the stock exchanges about this corporate development under regulatory disclosure requirements.
Mr. Pradeep M. Chandan has resigned from his position as Company Secretary, Compliance Officer, and Key Managerial Personnel (KMP) of Themis Medicare Limited. The resignation became effective from February 13, 2026.
The company formally communicated this development to both major stock exchanges on February 14, 2026. The notification was sent to BSE Limited (Scrip Code: 530199) and National Stock Exchange of India Limited (Symbol: THEMISMED) under reference number TML/BSE/NSE/2025-26/52.
Reason for Resignation
In his resignation letter dated February 12, 2026, Mr. Chandan stated that he was resigning due to other professional commitments. He requested the Board of Directors to accept his resignation and relieve him from his position with immediate effect. The outgoing Company Secretary expressed sincere gratitude to the management and Board of Directors for their support, guidance, and cooperation during his tenure.
The resignation notification was signed by Mr. Dinesh S. Patel, Chairman & Director (DIN: 00033273), confirming the company’s compliance with regulatory disclosure requirements under Regulation 30. The company will need to appoint a new Company Secretary and Compliance Officer to fill the vacant positions in accordance with regulatory requirements.
Impact on Investors
The resignation of the Company Secretary and Compliance Officer may have a minor impact on the company’s stock price in the short term. However, it is essential for investors to consider the company’s overall performance and future prospects before making any investment decisions. To learn more about how to invest in the stock market, visit our website.
Themis Medicare Limited is a pharmaceutical company that has been performing well in recent years. The company has a strong product portfolio and a significant presence in the Indian pharmaceutical market. To know more about the pharmaceutical industry in India, click here.
Regulatory Requirements
The company’s compliance with regulatory requirements is crucial for maintaining investor confidence. The resignation of the Company Secretary and Compliance Officer highlights the importance of regulatory compliance in the pharmaceutical industry. For more information on regulatory requirements for pharmaceutical companies, visit our website.
Conclusion
In conclusion, the resignation of the Company Secretary and Compliance Officer of Themis Medicare Limited is a significant development that may have a minor impact on the company’s stock price. However, investors should consider the company’s overall performance and future prospects before making any investment decisions. To stay updated with the latest news and developments in the Indian stock market, visit our website and learn more about Indian stock market news.